Drugs made of mRNA have the potential to transform medicine—if only they could get into cells in one piece. Now, University of Connecticut researchers have shown that packaging mRNA like a virus could ...

Like Rett syndrome, Pitt Hopkins syndrome is a rare neurodevelopmental disorder, though it doesn’t involve regression.

Researchers from New England Biolabs and Yale University have created a system for engineering the first fully synthetic ...

In experiments with mice, Johns Hopkins Medicine scientists report new evidence that precursors of myelin-producing cells - one of the few brain cell types that continue to be produced in the adult ...

Danish researchers have created new cell lines that need a less tailored feeding schedule and produce fewer waste products. The team, from the Technical University of Denmark (DTU), says they’ve ...

A small number of cancer cells with the ability to change their identities and behaviors appear to be a key driver of cancer progression and its ability to evolve resistance to treatment. Targeting ...

Pancreatic acinar organoid composed of polarized acinar cells displaying an enlarged Golgi complex (cyan) and expressing the digestive enzyme carboxypeptidase (magenta). The lumen enclosing fluid ...

In the cult classic gangster film 'Scarface', Tony Montana, a kingpin smuggler played by Al Pacino, leaves a fancy restaurant while angrily ranting about all the wealthy people who look down their ...

The discovery that tissues use electricity to expel unhealthy cells is part of a surge of renewed interest in the currents flowing through our bodies. We’re used to thinking of the brain as an ...

One of the most interesting updates in the solar energy space comes from the Hebrew University of Jerusalem (via EES Solar), where researchers have developed 3D-printed, semi-transparent, flexible ...

Scientists have discovered that T cell receptors activate through a hidden spring-like motion that had never been seen before. This breakthrough may help explain why immunotherapy works for some ...

MSK hematologist-oncologist Dr. Lia Palomba led a clinical trial that resulted in FDA approval of lisocabtagene maraleucel (Breyanzi®), a CAR T cell therapy, for marginal zone lymphoma. Marginal zone ...